share_log

ProKidney Analyst Ratings

Benzinga Analyst Ratings ·  Sep 2, 2022 09:34
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/02/2022 — Evercore ISI Group Initiates Coverage On → Outperform

ProKidney Questions & Answers

What is the target price for ProKidney (PROK)?

The latest price target for ProKidney (NASDAQ: PROK) was reported by Evercore ISI Group on September 2, 2022. The analyst firm set a price target for $0.00 expecting PROK to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for ProKidney (PROK)?

The latest analyst rating for ProKidney (NASDAQ: PROK) was provided by Evercore ISI Group, and ProKidney initiated their outperform rating.

When is the next analyst rating going to be posted or updated for ProKidney (PROK)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProKidney, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProKidney was filed on September 2, 2022 so you should expect the next rating to be made available sometime around September 2, 2023.

Is the Analyst Rating ProKidney (PROK) correct?

While ratings are subjective and will change, the latest ProKidney (PROK) rating was a initiated with a price target of $0.00 to $0.00. The current price ProKidney (PROK) is trading at is $9.94, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment